| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |